Date | Name | Activity | Value |
---|---|---|---|
Jan 08, 2024 | Paul Andrew Moore Chief Scientific Officer | Sold | $105699 |
Jan 08, 2024 | Kenneth Galbraith Chairman & Chief Executive Officer | Sold | $257845 |
Jan 08, 2024 | Christopher Astle Senior Vice President & Chief Financial Officer | Sold | $64655 |
Date | Firm | Activity | Value |
---|---|---|---|
Mar 31, 2024 | Bought | $4401315 | |
Mar 31, 2024 | Sold | $16842520 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
13,437,473 | Insider | 19.01% | 114,352,895 | |
6,075,918 | Insider | 8.59% | 51,706,062 | |
3,814,493 | Institution | 5.39% | 32,461,335 | |
2,898,647 | Insider | 4.10% | 24,667,486 | |
2,852,579 | Institution | 4.03% | 24,275,447 | |
2,556,874 | Institution | 3.62% | 21,758,998 | |
2,049,493 | Institution | 2.90% | 17,441,185 | |
1,974,691 | Insider | 2.79% | 16,804,620 | |
1,974,691 | Insider | 2.79% | 16,804,620 | |
1,601,000 | Institution | 2.26% | 13,624,510 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
2,049,493 | Institution | 2.90% | 17,441,185 | |
602,229 | Institution | 0.85% | 5,124,969 | |
523,983 | Institution | 0.74% | 4,459,095 | |
406,900 | Institution | 0.58% | 3,462,719 | |
309,039 | Institution | 0.44% | 2,629,922 | |
240,644 | Institution | 0.34% | 2,047,880 | |
237,663 | Institution | 0.34% | 2,022,512 | |
237,038 | Institution | 0.34% | 2,017,193 | |
137,800 | Institution | 0.19% | 1,172,678 | |
125,491 | Institution | 0.18% | 1,067,928 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
2,132,127 | Institution | 3.02% | 18,080,437 | |
1,292,965 | Institution | 1.83% | 11,003,132 | |
1,225,628 | Institution | 1.73% | 10,307,531 | |
774,421 | Institution | 1.10% | 6,512,881 | |
774,421 | Institution | 1.10% | 6,512,881 | |
493,863 | Institution | 0.70% | 4,202,774 | |
489,690 | Institution | 0.69% | 4,167,262 | |
318,262 | Institution | 0.45% | 2,676,583 | |
209,767 | Institution | 0.30% | 1,778,824 | |
126,435 | Institution | 0.18% | 1,732,192 |